Patent details

EP2515876 Title: PHARMACEUTICAL COMPOSITIONS AND ORAL DOSAGE FORMS OF A LEVODOPA PRODRUG AND METHODS OF USE

Basic Information

Publication number:
EP2515876
PCT Application Number:
PCT/US/2010/002937
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP107787483
PCT Publication Number:
WO/2011/056240
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHARMACEUTICAL COMPOSITIONS AND ORAL DOSAGE FORMS OF A LEVODOPA PRODRUG AND METHODS OF USE
French Title of Invention:
COMPOSITIONS PHARMACEUTIQUES ET FORMES GALÉNIQUES ORALES D'UN PROMÉDICAMENT DE LÉVODOPA ET PROCÉDÉS D'UTILISATION
German Title of Invention:
PHARMAZEUTISCHE ZUSAMMENSETZUNGEN UND ORALE DARREICHUNGSFORMEN EINES LEVODOPA-PRODRUGS UND ANWENDUNGSVERFAHREN
SPC Number:

Dates

Filing date:
08/11/2010
Grant date:
06/01/2016
EP Publication Date:
06/01/2016
PCT Publication Date:
12/05/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
31/10/2012
EP B1 Publication Date:
06/01/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
08/11/2016
Expiration date:
08/11/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
08/11/2010
 
 

Name:
XenoPort Inc.
Address:
3410 Central Expressway, Santa Clara, CA 95051, United States (US)

Inventor

1

Name:
MAURER Laura E.
Address:
United States (US)

2

Name:
MAO Chen
Address:
United States (US)

3

Name:
PARGAONKAR Nikhil
Address:
United States (US)

4

Name:
MA Sarina Grace Harris
Address:
United States (US)

Priority

Priority Number:
259567 P
Priority Date:
03/01/2001
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 9/16;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages